CN Patent

CN104276960B — 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Assigned to Anhui Heal Star Pharmaceutical Co.,Ltd. · Expires 2016-09-28 · 10y expired

What this patent protects

本发明涉及盐酸他喷他多和塞来昔布的新型共晶体，涉及用于制备共晶的方法及含有所述共晶的药物组合物，还涉及此共晶体用于治疗疼痛，包括急性痛、慢性痛、神经性疼痛、伤害性疼痛、轻度和重度痛感减退、痛觉过敏、与中枢致敏相关的疼痛、异常性疼痛或癌痛的药物中的用途。

USPTO Abstract

本发明涉及盐酸他喷他多和塞来昔布的新型共晶体，涉及用于制备共晶的方法及含有所述共晶的药物组合物，还涉及此共晶体用于治疗疼痛，包括急性痛、慢性痛、神经性疼痛、伤害性疼痛、轻度和重度痛感减退、痛觉过敏、与中枢致敏相关的疼痛、异常性疼痛或癌痛的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104276960B
Jurisdiction
CN
Classification
—
Expires
2016-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Anhui Heal Star Pharmaceutical Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.